Mariko Kajikawa
Bayer (Japan)(JP)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Pancreatic function and diabetes, Cardiac Arrhythmias and Treatments, Venous Thromboembolism Diagnosis and Management, Cardiac electrophysiology and arrhythmias
Most-Cited Works
- → Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation(2012)632 cited
- → Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice(1999)453 cited
- → An Insulinotropic Effect of Vitamin D Analog with Increasing Intracellular Ca2+ Concentration in Pancreatic β-Cells through Nongenomic Signal Transduction1(1999)109 cited
- → Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program(2015)109 cited
- → Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation(2012)104 cited
- → A genome-wide gain-of-function analysis of rice genes using the FOX-hunting system(2007)102 cited
- → Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation(2013)71 cited
- → Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age(2014)64 cited
- → Ouabain Suppresses Glucose-Induced Mitochondrial ATP Production and Insulin Release by Generating Reactive Oxygen Species in Pancreatic Islets(2002)63 cited
- → Overexpression of TIFY genes promotes plant growth in rice through jasmonate signaling(2017)57 cited